GlaxoSmithKline | GSK - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.96 0.93 2026-06
Alcon AG 42.44 6.03 2026-06
Almirall 79.43 0.3 2025-12
Amgen 18.07 1.77 2026-06
argenx SE 35.53 3.41 2026-06
AstraZeneca 25.34 4.25 2026-06
Bayer 4.14 0.74 2026-06
Biogen 23.23 9.53 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Eli Lilly 32.9 7.37 2026-06
Fresenius 11.44 4.91 2026-06
Fresenius Medical Care 12.13 5.49 2026-06
Genmab 16.04 1.05 2026-06
Gilead Sciences 13.51 4.2 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
Glaxosmithkline 15.09 3.43 2026-03
GRIFOLS 14.71 3.73 2026-06
Hikma Pharmaceutical 10.43 3.72 2025-12
Lakefront Biotherapeutics 2.68 0.14 2026-06
Lonza 34.34 2.58 2025-12
Merck 17.21 4.47 2026-06
Merck 32.26 15.74 2026-06
Novartis 22.41 2.24 2026-06
Novo Nordisk 10.17 2.61 2026-06
Orion 17.23 1.3 2026-06
Pfizer 11.48 2.16 2026-06
Philips 23.76 9.44 2026-06
Recordati 22.75 5.09 2026-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 18.96 7.12 2026-06
Smith & Nephew 13.76 3.86 2026-06
UCB 29.7 5.52 2025-12